Literature DB >> 2213800

Comparison of a dimethicone/antacid (Asilone gel) with an alginate/antacid (Gaviscon liquid) in the management of reflux oesophagitis.

H L Smart1, M Atkinson.   

Abstract

Fifty-three patients with symptomatic reflux oesophagitis were entered into a single centre randomized study comparing the effects of a dimethicone/antacid (Asilone Gel) and an alginate/antacid (Gaviscon liquid) on symptoms and endoscopic changes over an 8-week period. Both treatments significantly improved heartburn, acid regurgitation and flatulence. Dimethicone/antacid but not alginate/antacid, produced a significant improvement in oesophagitis, oesophageal ulceration and histological grade of inflammation over the 8-week treatment period so that 14 patients treated with dimethicone/antacid and 10 with alginate/antacid had normal endoscopic oesophageal appearances at the end of the study. The difference in improvement between the two patient groups did not reach significance however, except for dimethicone/antacid improving histological changes (P less than 0.05). These findings suggest that dimethicone/antacid and alginate/antacid are equally effective in treating symptomatic reflux oesophagitis although dimethicone/antacid may have an advantage in improving oesophageal histological appearances.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2213800      PMCID: PMC1292812          DOI: 10.1177/014107689008300907

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  8 in total

1.  A multicentric, randomized clinical trial of Gaviscon in reflux esophagitis.

Authors:  G McHardy
Journal:  South Med J       Date:  1978-01       Impact factor: 0.954

2.  Ambulatory esophageal pH recording in gastroesophageal reflux: relevance to the development of esophagitis.

Authors:  T Rokkas; G E Sladen
Journal:  Am J Gastroenterol       Date:  1988-06       Impact factor: 10.864

3.  Alginate-antacid in the reduction of gastro-oesophageal reflux.

Authors:  C Stanciu; J R Bennett
Journal:  Lancet       Date:  1974-01-26       Impact factor: 79.321

4.  Medical therapy for reflux esophagitis: 1986 and beyond.

Authors:  D O Castell
Journal:  Ann Intern Med       Date:  1986-01       Impact factor: 25.391

5.  The effect of free silica on the mucosal protective and antiflatulent properties of polydimethylsiloxane.

Authors:  R D Birtley; J S Burton; D N Kellett; B J Oswald; J C Pennington
Journal:  J Pharm Pharmacol       Date:  1973-11       Impact factor: 3.765

6.  Does dimethicone increase the efficacy of antacids in the treatment of reflux oesophagitis?

Authors:  A L Ogilvie; M Atkinson
Journal:  J R Soc Med       Date:  1986-10       Impact factor: 5.344

7.  Evaluation of elevation of the head of the bed, bethanechol, and antacid form tablets on gastroesophageal reflux.

Authors:  L F Johnson; T R DeMeester
Journal:  Dig Dis Sci       Date:  1981-08       Impact factor: 3.199

8.  Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis.

Authors:  E C Klinkenberg-Knol; J M Jansen; H P Festen; S G Meuwissen; C B Lamers
Journal:  Lancet       Date:  1987-02-14       Impact factor: 79.321

  8 in total
  4 in total

1.  Thiolated silicone oil: synthesis, gelling and mucoadhesive properties.

Authors:  Alexandra Partenhauser; Flavia Laffleur; Julia Rohrer; Andreas Bernkop-Schnürch
Journal:  Acta Biomater       Date:  2015-02-04       Impact factor: 8.947

2.  Preparation and evaluation of berberine alginate beads for stomach-specific delivery.

Authors:  Zhen-Hai Zhang; Yong-Shun Sun; Hui Pang; Were L L Munyendo; Hui-Xia Lv; Sheng-Liang Zhu
Journal:  Molecules       Date:  2011-12-14       Impact factor: 4.411

3.  A real-world evidence study evaluating Geffer effervescent granules for the symptomatic relief of digestive symptoms.

Authors:  Matteo Alemanni; Raffaella de Salvo; Barbara Moroni; Andreas Ehret
Journal:  SAGE Open Med       Date:  2022-03-29

4.  Current pharmacological management of gastroesophageal reflux disease.

Authors:  Yao-Kuang Wang; Wen-Hung Hsu; Sophie S W Wang; Chien-Yu Lu; Fu-Chen Kuo; Yu-Chung Su; Sheau-Fang Yang; Chiao-Yun Chen; Deng-Chyang Wu; Chao-Hung Kuo
Journal:  Gastroenterol Res Pract       Date:  2013-06-26       Impact factor: 2.260

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.